triamcinolone acetonide has been researched along with Uveitis in 114 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (6.14) | 18.7374 |
1990's | 5 (4.39) | 18.2507 |
2000's | 37 (32.46) | 29.6817 |
2010's | 48 (42.11) | 24.3611 |
2020's | 17 (14.91) | 2.80 |
Authors | Studies |
---|---|
Brodie, F; Gabr, H; Grewal, DS; Sastry, A | 1 |
Ciulla, TA; Hall, C; Kapik, B; Merrill, P; Singer, MA; Yeh, S | 1 |
Campbell, TG; Lin, ML | 1 |
Hikichi, T | 1 |
Fung, S; Syed, YY | 1 |
Albini, TA; Bhattacharyya, S; Dutta, SK; Hariprasad, SM; Harrison, D; John, D; Joseph, G; Padula, WV | 1 |
Chen, PH; Hsieh, YH; Hwang, YS; Jhou, HJ | 1 |
Ciulla, T; Yeh, S | 1 |
Benoit, JP; Formica, ML; Luna, JD; Palma, SD; Tártara, LI; Ullio Gamboa, GV | 1 |
Borkar, DS; McKay, KM; Papaliodis, GN; Sevgi, DD; Sobrin, L; Susarla, G | 1 |
Begum, G; Denniston, AK; Hill, LJ; Jones, MC; Katare, OP; Nirbhavane, P; Rauz, S; Sharma, G; Singh, B; Vincent, R | 1 |
Ciulla, TA; Henry, CR; Khurana, RN; Kissner, JM; Noronha, G; Shah, M; Wang, RC; Yeh, S | 1 |
Barakat, MR; Ciulla, T; Dayani, P; Hall, C; Henry, CR; Khurana, RN; Rifkin, L; Shah, M; Wang, RC; Yeh, S | 1 |
Barakat, MR; Ciulla, T; Henry, CR; Kapik, B; Khurana, RN; Merrill, P; Shah, M; Suhler, E; Uchiyama, E; Wang, RC; Yeh, S | 1 |
Niederer, RL; Pc Ong, A; Sims, JL | 1 |
Du, S; Pan, L; Ren, Y; Shi, Y; Yan, H; Zheng, D | 1 |
Ciulla, TA; Henry, CR; Kapik, B; Merrill, PT; Nguyen, QD; Reddy, A | 1 |
Anand, N; Jones, NP; Moraji, J; Steeples, LR | 1 |
Arevalo, JF; Couto, C; Díaz-Llopis, M; El-Haig, WM; Lasave, AF; Schlaen, A; Zeballos, DG | 1 |
Lei, L; Li, X; Song, Q; Xiong, T; Zhang, R; Zhou, Y | 1 |
Heiligenhaus, A; Pleyer, U; Walscheid, K | 1 |
Arepalli, S; Baynes, K; Bena, J; Ganapathy, PS; Li, M; Lowder, CY; Srivastava, SK | 1 |
Benesty, J; Bensemlali, A; Bodaghi, B; Errera, MH; Falah, S; Goldschmidt, P; Héron, E; Orès, R; Pratas, AC; Sahel, JA; Sedira, N; Smadja, J; Westcott, M | 1 |
Do, DV; Foster, CS; Kurup, SK; Nguyen, QD; Noronha, G; Wang, RC; Yeh, S | 1 |
Huang, J; Li, X; Song, Q; Wang, Q; Yu, X; Zhang, R; Zhou, Y | 1 |
Brennan, J; Hall, AJ; Hodgson, L; Lim, LL; Ma, SP; Rogers, SL; Stawell, RJ | 1 |
Acharya, NR; Altaweel, MM; Burke, AE; Holbrook, JT; Jabs, DA; Kempen, JH; Sugar, EA; Thorne, JE; Vitale, AT | 1 |
Bi, H; Guo, D; Guo, J; Li, Q; Sun, Y; Wei, H; Wu, S; Yin, X; Zhao, Q | 1 |
Novack, GD | 1 |
Abu Al-Fadl, EM; Arcinue, CA; Artornsombudh, P; Foster, CS; Radwan, AE; Yang, P | 1 |
Ober, MD; Valijan, S | 1 |
Bolz, M; Eisenkölbl, S; Huf, W; Kiss, C; Munk, M; Sayegh, R; Schmidt-Erfurth, U; Simader, C; Sulzbacher, F | 1 |
Butler, NJ; Dunn, JP; Gan, TJ; Leder, HA; Salek, SS; Thorne, JE | 1 |
Eskandari, A; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Soheilian, R | 1 |
Amin, SR; Pulido, JS | 1 |
Adibkia, K; Atyabi, F; De Geest, BG; Dinarvand, R; Ghahremani, MH; Hashemi, H; Khoshayand, MR; Mohsenzadeh, N; Sabzevari, A | 1 |
Dai, W; He, B; Li, W; Liu, Y; Zhang, Q | 1 |
Bar, A; Din, NM; Isa, H; Lightman, S; Talat, L; Taylor, SR; Tomkins-Netzer, O | 1 |
Foster, CS; Gangaputra, SS; Jabs, DA; Kempen, JH; Levy-Clarke, GA; Liesegang, TL; Nussenblatt, RB; Rosenbaum, JT; Sen, HN; Suhler, EB; Thorne, JE; Vitale, S | 1 |
Bleriot, A; Couret, C; Le Meur, G; Lebranchu, P; Weber, M | 1 |
Chen, H; Jin, L; Li, X; Luo, Z; Shi, S; Wang, Y; Yang, C; Yang, Z; Yu, J; Zhang, Z | 1 |
Ayyıldız, O; Durukan, AH; Gunal, A; Ozgurtas, T | 1 |
Cho, H; Nicholson, L; Pillai, P; Sobrin, L | 1 |
Adan, A; Fonollosa, A; Mesquida, M | 1 |
Chau, F; Goldstein, DA; Liu, D; Munk, MR; Rademaker, A; Ram, R; Schmidt-Erfurth, U; Setlur, V | 1 |
Shin, JY; Yu, HG | 1 |
Gao, F; Liu, X; Wang, M; Zhang, M; Zhao, C | 1 |
Denniston, AK; Keane, PA; Macdonald, T; Murray, PI; Sim, DA; Sreekantam, S | 1 |
Jia, Y; Miao, H; Wang, L; Yang, Y; Zhang, XY; Zhou, YS | 1 |
Schulze-Döbold, C; Weber, M | 1 |
Heiligenhaus, A; Heinz, C; Koch, JM; Roesel, M | 2 |
Spaide, RF | 1 |
Heiligenhaus, A; Heinz, C; Koch, JM; Roesel, M; Tappeiner, C | 1 |
Gutfleisch, M; Heiligenhaus, A; Heimes, B; Heinz, C; Roesel, M; Zurek-Imhoff, B | 3 |
Adán, A; Corretger, X; Gris, O; Pelegrin, L; Torras, J | 1 |
Habot-Wilner, Z; Lightman, S; Sallam, A; Sheth, HG | 1 |
Kim, SY; Kim, YM; Lee, JW; Lim, JO; Oh, JH; Park, YC; Shin, JP | 1 |
McCluskey, P; Younan, C | 1 |
Abela-Formanek, C; Barisani-Asenbauer, T; Benesch, T; Kiss, CG; Maca, SM; Sacu, SG | 1 |
Kiernan, DF; Mieler, WF | 1 |
Dubey, S; Gandhi, M; Nazm, N; Pegu, J | 1 |
Kiavash, V; Peyman, GA; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Yaseri, M | 2 |
Alkawas, AA; Hamdy, AM; Shahien, EA | 1 |
Bae, JH; Lee, CS; Lee, SC | 1 |
Grigg, JR; Habot-Wilner, Z; Kabasele, PM; Lightman, S; McCluskey, P; Roufas, A; Sallam, A | 1 |
Dunn, JP; Galor, A; Jabs, DA; Leder, HA; Thorne, JE | 1 |
Behar-Cohen, FF; Bousquet, E; Farman, N; Jaisser, F; Jeanny, JC; Valamanesh, F; Zhao, M | 1 |
Do, HH; Elgohary, M; Habot-Wilner, Z; Lightman, S; McCluskey, P; Sallam, A; Taylor, SR | 1 |
Banifatemi, M; Rahimi, M; Shahrzad, SS | 1 |
Do, HH; Habot-Wilner, Z; Lightman, S; McCluskey, P; Pacheco, PA; Sallam, A | 1 |
Zaborowski, AG | 1 |
Balaskas, K; Eperon, S; Guex-Crosier, Y; Gurny, R; Rodriguez-Aller, M | 1 |
Adibkia, K; Atyabi, F; Dinarvand, R; Ghahremani, MH; Hashemi, H; Hedayatfar, A; Mohsenzadeh, N; Sabzevari, A | 1 |
Ha, SW; Kim, SY; Park, DH; Shin, JP | 1 |
Adam, R; Bodaghi, B; Bui Quoc, E; Burtin, T; Cassoux, N; Dreifuss, S; Fardeau, C; LeHoang, P | 1 |
Degenring, RF; Jonas, JB | 1 |
Enaida, H; Ishibashi, T; Kawano, YI; Kubota, T; Nakamura, T; Sakamoto, T; Sonoda, KH; Ueno, A | 1 |
ANHALT, EF; BLAYDES, JE; KARA, GB; ZAVELL, S | 1 |
Degenring, RF; Jonas, JB; Kamppeter, B; Kreissig, I | 1 |
Haamann, PH; Klitgaard, TL; Larsen, M; Villumsen, JE | 1 |
Das-Bhaumik, RG; Jones, NP | 1 |
Kok, H; Lau, C; Lightman, S; Maycock, N; McCluskey, P | 1 |
Angunawela, RI; Antcliffe, RJ; Graham, EM; Heatley, CJ; Spalton, DJ; Stanford, MR; Williamson, TH | 1 |
Lee, VY; Li, CL; Liu, DT | 1 |
de Vries, P; Rothova, A; van Kooij, B | 1 |
Hisatomi, T; Kubota, T; Okabe, H; Sakamoto, T; Tawara, A; Yamakiri, K | 1 |
Budde, WM; Harder, B; Jonas, JB; Kamppeter, BA; Sauder, G; Spandau, UH | 1 |
Heiligenhaus, A; Heinz, C; Li, J; Zurek-Imhoff, B | 1 |
Gutfleisch, M; Heiligenhaus, A; Lommatzsch, A; Mingels, A; Pauleikhoff, D; Spital, G | 1 |
Cano-Parra, J; Díaz-Llopis, M | 1 |
Gunnarsdóttir, SG; Gunnlaugsdóttir, E; Oehman, DO; Stefánsson, E | 1 |
Boldt, C; Carter, KD; Folk, J; Nerad, JA; Song, A | 1 |
Azen, SP; Freeman, WR; Kayicioglu, OO; Kozak, I; LaBree, LD; Morrison, VL | 1 |
Chung, JY; Kaiser, PK; Lowder, CY; Perez, VL; Singh, RP; Taban, M | 1 |
Brasil, OM; Galor, A; Kaiser, PK; Lowder, CY; Margolis, R; Perez, VL; Sears, JE; Smith, SD | 1 |
Andrews, R; Chang, JH; Comer, RM; Grigg, JR; Lightman, S; McCluskey, PJ; Sallam, A | 1 |
Smecka, Z; Smecková, M | 2 |
Eckardt, C | 1 |
Akduman, L; Black, DL; Del Priore, LV; Kaplan, HJ; Kolker, AE | 1 |
Modarres, M; Parvaresh, MM; Peyman, GA | 1 |
Biswas, J; Raghavendran, SR; Vijaya, R | 1 |
Antcliff, RJ; ffytche, TJ; Graham, EM; Marshall, J; Spalton, DJ; Stanford, MR | 1 |
Jonas, JB | 1 |
Benítez Del Castillo Sánchez, JM; García Sánchez, J | 1 |
Hall, JM; Meyer, RF; Okumoto, M; Smolin, G | 1 |
Belfort, R; Hall, JM; Okumoto, M; Smolin, G | 1 |
Guex-Crosier, Y; Herbort, CP; Othenin-Girard, P | 1 |
Johnston, CA; Teitelbaum, CS | 1 |
Culbertson, CG; Schlaegel, TF | 1 |
5 review(s) available for triamcinolone acetonide and Uveitis
Article | Year |
---|---|
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema.
Topics: Choroidal Effusions; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Multicenter Studies as Topic; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis | 2022 |
Intravitreal injection versus systematic treatment in patients with uveitis undergoing cataract surgery: a systematic review and meta-analysis.
Topics: Cataract; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Macular Edema; Phacoemulsification; Treatment Outcome; Triamcinolone Acetonide; Uveitis | 2023 |
The use of intraocular corticosteroids.
Topics: Animals; Anti-Inflammatory Agents; Clinical Trials as Topic; Drug Implants; Glucocorticoids; Humans; Injections; Macular Degeneration; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2009 |
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris Diseases; Macular Degeneration; Macular Edema; Ocular Hypotension; Ophthalmia, Sympathetic; Papilledema; Photochemotherapy; Retinal Diseases; Retinal Neovascularization; Retinal Vein Occlusion; Time Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2004 |
The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.
Topics: Glucocorticoids; Humans; Injections; Macular Edema; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2006 |
16 trial(s) available for triamcinolone acetonide and Uveitis
Article | Year |
---|---|
Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE.
Topics: Glucocorticoids; Humans; Macular Edema; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2022 |
Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial.
Topics: Choroid; Female; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2020 |
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA).
Topics: Glucocorticoids; Humans; Macular Edema; Magnolia; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis | 2022 |
SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS: A Randomized, Phase 2 Study (DOGWOOD).
Topics: Adult; Aged; Aged, 80 and over; Choroid; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Young Adult | 2019 |
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dexamethasone; Drug Administration Routes; Drug Implants; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Young Adult | 2019 |
A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Young Adult | 2013 |
Intravitreal Triamcinolone Injection for Uveitic Macular Edema: A Randomized Clinical Study.
Topics: Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2015 |
Cataract surgery in uveitis.
Topics: Administration, Oral; Anterior Chamber; Cataract; Combined Modality Therapy; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Intraoperative Care; Lens Implantation, Intraocular; Macular Edema; Phacoemulsification; Prednisolone; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2008 |
Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis.
Topics: Anti-Inflammatory Agents; Chronic Disease; Drug Administration Routes; Female; Humans; Injections; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Orbit; Phacoemulsification; Postoperative Care; Prospective Studies; Pseudophakia; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2009 |
[Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis].
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Injections; Male; Middle Aged; Prevalence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2009 |
Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis.
Topics: Administration, Oral; Anterior Chamber; Cataract; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Intraoperative Care; Lens Implantation, Intraocular; Male; Middle Aged; Orbit; Phacoemulsification; Photometry; Postoperative Complications; Prednisolone; Prospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2010 |
Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Pilot Projects; Retina; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Bevacizumab vs. triamcinolone.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Disease Progression; Female; Glucocorticoids; Humans; Macula Lutea; Macular Edema; Male; Pilot Projects; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Visual Acuity | 2010 |
Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
Topics: Adolescent; Adult; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Humans; Immunotherapy; Macular Edema; Male; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Vision, Ocular; Young Adult | 2012 |
[Effects of locally administered corticosteroids on mineral metabolism].
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Cataract Extraction; Clinical Trials as Topic; Dexamethasone; Female; Fludrocortisone; Glucocorticoids; Humans; Male; Minerals; Ophthalmic Solutions; Potassium; Prednisolone; Random Allocation; Sodium; Triamcinolone Acetonide; Uveitis | 1984 |
[Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema].
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Diclofenac; Female; Humans; Injections; Lenses, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Prednisolone; Prospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity | 1992 |
93 other study(ies) available for triamcinolone acetonide and Uveitis
Article | Year |
---|---|
DELAYED ONSET Cutibacterium (FORMERLY Propionibacterium ) acnes ENDOPHTHALMITIS TRIGGERED BY INTRAVITREAL STEROID INJECTION.
Topics: Aged; Anti-Bacterial Agents; Cataract; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Male; Propionibacterium; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2023 |
Suprachoroidal steroids for uveitic macular oedema: Teaching an old drug new tricks?
Topics: Glucocorticoids; Humans; Macular Edema; Triamcinolone Acetonide; Uveitis | 2022 |
Sub-Tenon's capsule triamcinolone acetonide injection to prevent brolucizumab-associated intraocular inflammation.
Topics: Antibodies, Monoclonal, Humanized; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Retrospective Studies; Tenon Capsule; Triamcinolone Acetonide; Uveitis | 2022 |
Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis.
Topics: Aged; Cost-Benefit Analysis; Glucocorticoids; Humans; Macular Edema; Medicare; Quality of Life; Treatment Outcome; Triamcinolone Acetonide; United States; Uveitis; Visual Acuity | 2022 |
Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with noninfectious uveitis: an in-depth look at efficacy and safety.
Topics: Choroid; Glucocorticoids; Humans; Macular Edema; Quality of Life; Treatment Outcome; Triamcinolone Acetonide; Uveitis | 2023 |
Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
Topics: Administration, Ophthalmic; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Drug Stability; Epithelium, Corneal; Humans; Lipids; Male; Nanocapsules; Particle Size; Rabbits; Solubility; Surface-Active Agents; Temperature; Triamcinolone Acetonide; Uveitis | 2020 |
Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis.
Topics: Adult; Aged; Female; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retrospective Studies; Tenon Capsule; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2021 |
Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity.
Topics: Animals; Anti-Inflammatory Agents; Biological Products; Cations; Cell Survival; Cells, Cultured; Chickens; Dose-Response Relationship, Drug; Drug Liberation; Humans; Lipids; Nanoparticles; Particle Size; Structure-Activity Relationship; Surface Properties; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha; Uveitis | 2020 |
Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA).
Topics: Eye Infections, Bacterial; Glucocorticoids; Humans; Macular Edema; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2022 |
Infectious Uveitis after Local Steroid and/or Methotrexate Injections at A Tertiary Referral Center in New Zealand: A Case Series.
Topics: Aged; Chorioretinitis; Cytomegalovirus Retinitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Intravitreal Injections; Methotrexate; Middle Aged; New Zealand; Retrospective Studies; Tertiary Care Centers; Triamcinolone Acetonide; Uveitis | 2022 |
Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract.
Topics: Cataract; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Phacoemulsification; Retrospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2021 |
Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A Post-Hoc Analysis of the Phase 3 PEACHTREE Clinical Trial.
Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis | 2023 |
Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Preservatives, Pharmaceutical; Retina; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2018 |
Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Visual Acuity; Young Adult | 2019 |
Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Biocompatible Materials; Dose-Response Relationship, Drug; Electroretinography; Glucosamine; Glycosylation; Hydrogels; Hydrogen Bonding; Inflammation; Intravitreal Injections; Macrophages; Male; Mice; Microscopy, Electron, Transmission; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; RAW 264.7 Cells; Retina; Rheology; Spectroscopy, Fourier Transform Infrared; Succinic Acid; Th1 Cells; Triamcinolone Acetonide; Uveitis | 2018 |
[Cataracts in Uveitis].
Topics: Cataract; Cataract Extraction; Glucocorticoids; Humans; Triamcinolone Acetonide; Uveitis | 2018 |
Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis.
Topics: Adult; Aged; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Preservatives, Pharmaceutical; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis | 2018 |
A Comparison of the Dexamethasone Implant (Ozurdex®) and Inferior Fornix-Based Sub-Tenon Triamcinolone Acetonide for Treatment of Inflammatory Ocular Diseases.
Topics: Adult; Aged; Dexamethasone; Drug Implants; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intraocular; Male; Middle Aged; Retrospective Studies; Tenon Capsule; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2019 |
Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Cell Line; Cornea; Humans; Hydrogels; Lipopolysaccharides; Mice; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers; Rabbits; Triamcinolone Acetonide; Uveitis | 2018 |
Sarcoidosis-related Uveitis: Clinical Presentation, Disease Course, and Rates of Systemic Disease Progression After Uveitis Diagnosis.
Topics: Adult; Biopsy; Diagnosis, Differential; Disease Progression; Eye Diseases; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphadenopathy; Male; Middle Aged; Prednisolone; Retrospective Studies; Risk Factors; Sarcoidosis; Time Factors; Tomography, X-Ray Computed; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2019 |
Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Female; Gene Expression Regulation; Humans; Interleukin-10; Interleukin-7; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Rats; Triamcinolone Acetonide; Uveitis | 2019 |
Treatment Duration and Side Effect Profile of Long-term Use of Intravitreal Preservative-free Triamcinolone Acetonide in Uveitis.
Topics: Duration of Therapy; Glucocorticoids; Humans; Triamcinolone Acetonide; Uveitis | 2019 |
Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bevacizumab; Bromobenzenes; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Retreatment; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2013 |
The duration of effect of centrifuge concentrated intravitreal triamcinolone acetonide.
Topics: Biological Availability; Centrifugation; Diabetic Retinopathy; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retinal Vasculitis; Retinal Vein Occlusion; Retrospective Studies; Time Factors; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2013 |
Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ranibizumab; Reading; Recovery of Function; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2013 |
Periocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intraocular; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Young Adult | 2013 |
Retinal vasculitis, aneurysms, and neovascularization in Blau syndrome.
Topics: Aneurysm; Arthritis; Child; Combined Modality Therapy; Cranial Nerve Diseases; DNA Mutational Analysis; Fluorescein Angiography; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Male; Nod2 Signaling Adaptor Protein; Peptidyl-Dipeptidase A; Retinal Artery; Retinal Neovascularization; Retinal Vasculitis; Retinitis; Sarcoidosis; Synovitis; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2013 |
Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
Topics: Absorbable Implants; Animals; Aqueous Humor; Disease Models, Animal; Drug Delivery Systems; Female; Glucocorticoids; Nanoparticles; Polymers; Rabbits; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2013 |
Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Drug Carriers; Glycolates; Intravitreal Injections; Lactic Acid; Microspheres; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Triamcinolone Acetonide; Uveitis | 2014 |
The influence of diabetes mellitus on the management and visual outcome of patients with uveitis.
Topics: Anti-Inflammatory Agents; Cataract; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Methylprednisolone; Methylprednisolone Acetate; Prediabetic State; Triamcinolone Acetonide; Uveitis; Vision, Low; Visual Acuity | 2014 |
Periocular corticosteroid injections in uveitis: effects and complications.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Glucocorticoids; Humans; Infant; Infant, Newborn; Injections, Intraocular; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2014 |
[Safety and efficacy of subconjunctival triamcinolone injections in the management of uveitic macular edema: retrospective study of thirty-one cases].
Topics: Adult; Anti-Inflammatory Agents; Cataract; Conjunctiva; Drug Evaluation; Epiretinal Membrane; Female; Humans; Injections, Intraocular; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2014 |
Supramolecular nanofibers of triamcinolone acetonide for uveitis therapy.
Topics: Animals; Autoimmune Diseases; Biological Transport; Hydrogels; Immunosuppressive Agents; Nanofibers; Rats; Rats, Inbred Lew; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis | 2014 |
A comparison of intravitreal bevacizumab and steroid activity in an experimental uveitis model.
Topics: Angiogenesis Inhibitors; Animals; Aqueous Humor; Bevacizumab; Disease Models, Animal; Glucocorticoids; Intravitreal Injections; Male; Rabbits; Serum Albumin, Bovine; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A | 2015 |
Inflammatory Papillitis in Uveitis: Response to Treatment and Use of Optic Nerve Optical Coherence Tomography for Monitoring.
Topics: Administration, Topical; Adolescent; Adult; Aged; Child; Drug Monitoring; Female; Fluprednisolone; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Nerve Fibers; Observer Variation; Ophthalmic Solutions; Optic Disk; Optic Nerve; Papilledema; Reproducibility of Results; Retinal Ganglion Cells; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis | 2016 |
Uveitic macular oedema after treatment with vemurafenib.
Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Drug Implants; Glucocorticoids; Humans; Indoles; Macular Edema; Male; Melanoma; Middle Aged; Prednisone; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Vemurafenib; Visual Acuity | 2015 |
Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema.
Topics: Adult; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Drug Implants; Eye Diseases; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Tissue Adhesions; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2015 |
[The efficacy and safety of subconjunctival triamcinolone acetonide injections in treatment of uveitic macular edema].
Topics: Anti-Inflammatory Agents; Conjunctiva; Humans; Injections, Intraocular; Intraocular Pressure; Macula Lutea; Macular Edema; Recurrence; Retreatment; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2015 |
Quantitative analysis of vitreous inflammation using optical coherence tomography in patients receiving sub-Tenon's triamcinolone acetonide for uveitic cystoid macular oedema.
Topics: Adult; Aged; Anti-Inflammatory Agents; Female; Humans; Inflammation; Injections, Intraocular; Longitudinal Studies; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body; Young Adult | 2017 |
[Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Arthritis; Cyclophosphamide; Disease Progression; Female; Hematologic Diseases; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Pain; Prognosis; Raynaud Disease; Recurrence; Scleritis; Serositis; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vision Disorders | 2016 |
Loss of visual function after repeated intravitreal injections of triamcinolone acetonide in refractory uveitic macular oedema.
Topics: Electroretinography; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Vision Disorders; Vitreous Body | 2009 |
Intravitreal triamcinolone.
Topics: Cataract; Disease Progression; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens Capsule, Crystalline; Macular Edema; Risk Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2008 |
Explantation of intraocular lenses in children with juvenile idiopathic arthritis-associated uveitis.
Topics: Arthritis, Juvenile; Cataract; Child; Device Removal; Female; Glucocorticoids; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Macular Edema; Phacoemulsification; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitrectomy | 2009 |
Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Chronic Disease; Female; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prednisolone; Prostaglandins F, Synthetic; Retrospective Studies; Tonometry, Ocular; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Young Adult | 2009 |
Biodegradable intrascleral implant of triamcinolone acetonide in experimental uveitis.
Topics: Absorbable Implants; Animals; Cell Count; Chronic Disease; Drug Administration Routes; Drug Carriers; Drug Compounding; Drug Implants; Electroretinography; Glucocorticoids; Polyesters; Rabbits; Sclera; Triamcinolone Acetonide; Tuberculin; Uveitis; Vitreous Body | 2009 |
Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
Topics: Cataract; Chronic Disease; Drug Administration Routes; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Orbit; Retrospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2009 |
Treatment of chronic uveitic cystoid macular oedema.
Topics: Chronic Disease; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2009 |
Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis.
Topics: Cataract; Chronic Disease; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2009 |
Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Topics: Acute Disease; Antihypertensive Agents; Chronic Disease; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Prednisolone; Prostaglandins F, Synthetic; Tonometry, Ocular; Triamcinolone Acetonide; Uveitis | 2010 |
Intraoperative intravitreal injection of triamcinolone acetonide for cataract extraction in patients with uveitis.
Topics: Adolescent; Adult; Cataract; Cataract Extraction; Female; Glucocorticoids; Humans; Inflammation; Injections, Intraocular; Intraoperative Care; Lens Implantation, Intraocular; Male; Middle Aged; Postoperative Complications; Postoperative Period; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body; Young Adult | 2010 |
Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Behcet Syndrome; Bevacizumab; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body; Young Adult | 2011 |
Periocular corticosteroid injection in the management of uveitis in children.
Topics: Adolescent; Cataract; Cataract Extraction; Child; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intraocular; Male; Methylprednisolone; Methylprednisolone Acetate; Orbit; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2010 |
Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2011 |
Differential regulations of AQP4 and Kir4.1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina.
Topics: Animals; Aquaporin 4; Blotting, Western; Dexamethasone; Dose-Response Relationship, Drug; Female; Fluorescent Antibody Technique, Indirect; Glucocorticoids; Immunohistochemistry; Intravitreal Injections; Potassium Channels, Inwardly Rectifying; Rats; Rats, Inbred Lew; Retina; Reverse Transcriptase Polymerase Chain Reaction; Triamcinolone Acetonide; Uveitis | 2011 |
Repeat intravitreal triamcinolone acetonide injections in uveitic macular oedema.
Topics: Cataract; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Recurrence; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2012 |
Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2011 |
Cytomegalovirus retinitis following intravitreal triamcinolone acetonide in a patient with chronic uveitis on systemic immunosuppression.
Topics: Chronic Disease; Cytomegalovirus Retinitis; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppression Therapy; Intravitreal Injections; Middle Aged; Triamcinolone Acetonide; Uveitis | 2013 |
A new drug delivery system inhibits uveitis in an animal model after cataract surgery.
Topics: Animals; Anti-Inflammatory Agents; Biocompatible Materials; Cataract Extraction; Cyclosporine; Disease Models, Animal; Drug Carriers; Drug Combinations; Drug Delivery Systems; Female; Lactic Acid; Lens Implantation, Intraocular; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Triamcinolone Acetonide; Uveitis | 2013 |
Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.
Topics: Animals; Aqueous Humor; Female; Nanoparticles; Particle Size; Polymers; Rabbits; Random Allocation; Treatment Outcome; Triamcinolone Acetonide; Uveitis; X-Ray Diffraction | 2013 |
Bilateral nongranulomatous uveitis with infective endocarditis.
Topics: Adult; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis, Bacterial; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2013 |
[Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Child; Female; Humans; Injections; Male; Middle Aged; Ocular Hypertension; Triamcinolone Acetonide; Uveitis | 2002 |
Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis.
Topics: Adolescent; Chronic Disease; Female; Glucocorticoids; Humans; Injections; Triamcinolone Acetonide; Uveitis | 2003 |
Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study.
Topics: Adult; Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative | 2003 |
Evaluation of kenacort (triamcinolone) in the treatment of uveitis.
Topics: Humans; Triamcinolone; Triamcinolone Acetonide; Uveitis | 1959 |
[Intravitreal triamcinolone therapy. New therapeutic alternative for patients with vision-threatening eye diseases].
Topics: Contraindications; Glucocorticoids; Humans; Injections; Macular Degeneration; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2005 |
Low-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chronic Disease; Female; Humans; Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2006 |
Outcome of intravitreal triamcinolone in uveitis.
Topics: Adolescent; Adult; Aged; Cataract; Chronic Disease; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Prednisolone; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body; Vitreous Hemorrhage | 2005 |
Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome.
Topics: Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Recurrence; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2005 |
The surgical management of chronic hypotony due to uveitis.
Topics: Chronic Disease; Glucocorticoids; Humans; Ocular Hypotension; Triamcinolone Acetonide; Uveitis | 2006 |
Ultrastructure of the trabecular meshwork in secondary glaucoma eyes after intravitreal triamcinolone acetonide.
Topics: Extracellular Matrix; Female; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Retinal Vein Occlusion; Trabecular Meshwork; Trabeculectomy; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2006 |
Triamcinolone acetonide-induced ocular hypertension.
Topics: Adult; Antihypertensive Agents; Diagnostic Techniques, Ophthalmological; Female; Glucocorticoids; Humans; Intraocular Pressure; Lasers; Nerve Fibers; Ocular Hypertension; Optic Disk; Optic Nerve Diseases; Tomography; Triamcinolone Acetonide; Uveitis | 2006 |
Intraoperative intraocular triamcinolone injection prophylaxis for post-cataract surgery fibrin formation in uveitis associated with juvenile idiopathic arthritis.
Topics: Anterior Chamber; Arthritis, Juvenile; Cataract; Cataract Extraction; Child; Female; Fibrinolysis; Glucocorticoids; Humans; Injections; Intraoperative Care; Male; Methylprednisolone; Postoperative Complications; Premedication; Triamcinolone Acetonide; Uveitis; Vitrectomy | 2006 |
Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations.
Topics: Adolescent; Adult; Aged; Cataract; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitrectomy; Vitreous Body | 2007 |
[New drugs in the treatment of noninfectious uveitis].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Clinical Trials as Topic; Daclizumab; Fluocinolone Acetonide; Humans; Immunoglobulin G; Infliximab; Injections; Ocular Hypertension; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2006 |
[Macular oedema and intravitreal triamcinolone injections].
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diabetic Retinopathy; Follow-Up Studies; Humans; Iceland; Injections; Macular Edema; Middle Aged; Phacoemulsification; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2006 |
Steroid-induced ptosis: case studies and histopathologic analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Blepharoptosis; Disease Models, Animal; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Oculomotor Muscles; Rabbits; Retrospective Studies; Triamcinolone Acetonide; Uveitis | 2008 |
Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2007 |
Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis.
Topics: Aged; Aged, 80 and over; Endophthalmitis; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2007 |
Adverse events after intravitreal triamcinolone in patients with and without uveitis.
Topics: Aged; Cataract; Disease Progression; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens Capsule, Crystalline; Macular Edema; Male; Middle Aged; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2007 |
Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children.
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Recurrence; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2008 |
Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis.
Topics: Adult; Anterior Chamber; Anti-Inflammatory Agents; Female; Humans; Injections; Macular Edema; Male; Middle Aged; Photometry; Retrospective Studies; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2009 |
Immunosuppressive therapy of experimental uveitis.
Topics: Animals; Autoimmune Diseases; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Immunization; Immunosuppressive Agents; Male; Methotrexate; Rabbits; Skin Tests; Time Factors; Triamcinolone Acetonide; Uveitis | 1984 |
The effect of corticosteroids on experimental uveitis.
Topics: Adrenal Cortex Hormones; Animals; Cortisone; Drug Evaluation, Preclinical; Female; Immunization; Male; Ophthalmic Solutions; Rabbits; Skin Tests; Time Factors; Triamcinolone Acetonide; Uveitis | 1984 |
Treatment of persistent glaucoma secondary to periocular corticosteroids.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Child; Fasciotomy; Glaucoma; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Orbit; Triamcinolone Acetonide; Uveitis | 1996 |
Accidental subretinal injection of triamcinolone acetonide.
Topics: Adult; Atrophy; Cataract Extraction; Choroid; Chronic Disease; Follow-Up Studies; Glucocorticoids; Humans; Injections; Lens Implantation, Intraocular; Male; Pigment Epithelium of Eye; Retinal Hemorrhage; Triamcinolone Acetonide; Uveitis; Visual Acuity | 1998 |
Intermediate uveitis of pars planitis type in identical twins. Report of a case.
Topics: Adolescent; Anti-Inflammatory Agents; Cytogenetic Analysis; Diseases in Twins; Female; Histocompatibility Testing; Humans; Injections; Pedigree; Triamcinolone Acetonide; Twins, Monozygotic; Uveitis | 1998 |
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.
Topics: Adult; Diagnostic Techniques, Ophthalmological; Female; Glucocorticoids; Humans; Injections; Interferometry; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Sound; Tomography; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2001 |
Therapeutic options for a 53-year-old black woman with concomitant glaucoma, uveitis, and cataract.
Topics: Cataract; Female; Glaucoma; Glucocorticoids; Humans; Injections; Middle Aged; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2001 |
[Intravitreal injection of triamcinolone acetonide in non infectious uveitis].
Topics: Adolescent; Adult; Female; Humans; Immunosuppressive Agents; Injections, Intralesional; Male; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2001 |
Effect of pretreatment with local corticosteroids on antibody-forming cells in the eye and draining lymph nodes.
Topics: Adrenal Cortex Hormones; Animals; Antibody Formation; Antibody-Producing Cells; Eye; gamma-Globulins; Hemolytic Plaque Technique; Keratitis; Lymph Nodes; Rabbits; Triamcinolone; Triamcinolone Acetonide; Uveitis | 1975 |
Effect of systemic corticosteroids on antibody-forming cells in the eye and draining lymph nodes.
Topics: Animals; Antibodies; Antibody-Producing Cells; Aqueous Humor; Keratitis; Lymph Nodes; Male; Rabbits; Triamcinolone Acetonide; Uveitis; Vitreous Body | 1977 |
Magnetic resonance imaging in Vogt-Koyanagi-Harada syndrome.
Topics: Administration, Oral; Adult; Chlorambucil; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Prednisone; Tomography, X-Ray Computed; Triamcinolone Acetonide; Uveitis; Uveomeningoencephalitic Syndrome | 1990 |
Experimental Hartmannella optic neuritis and uveitis.
Topics: Amebiasis; Animals; Chorioretinitis; Female; Hartmannella; Male; Optic Neuritis; Rabbits; Time Factors; Triamcinolone Acetonide; Uveitis | 1972 |